Evidence map›Paper›PMID 24847348›Full record

ArticleCase reports in nephrology and urology2014

A Case of Membranous Glomerulonephropathy Associated with Takayasu's Arteritis.

Ryo Koda, Atsunori Yoshino, Yuji Imanishi, Shinya Kawamoto, Yoshihiko Ueda, Junichiro James Kazama, Ichiei Narita, Tetsuro Takeda

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in nephrology and urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Can Takayasu Arteritis Cause Hydronephrosis?Internal medicine (Tokyo, Japan) · 2023
    Article
  6. Article
  7. Article
  8. Takayasu's disease effects on the kidneys: current perspectives.International journal of nephrology and renovascular disease · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ryo KodaDepartment of Nephrology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Atsunori YoshinoDepartment of Nephrology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Yuji ImanishiDepartment of Nephrology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Shinya KawamotoDepartment of Nephrology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Yoshihiko UedaDepartment of Pathology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Junichiro James KazamaDepartment of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ichiei NaritaDepartment of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Tetsuro TakedaDepartment of Nephrology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
Dokkyo Medical University Saitama Medical Center · JPNiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glomerulonephropathy is a rare complication of Takayasu's arteritis (TA). To date, most glomerulonephropathies associated with TA show the histological feature of mesangial proliferation. Membranous glomerulonephropathy (MG) is a form of glomerulonephropathy in which the mesangial proliferation is not conspicuous and its association with TA is extremely rare. A 54-year-old man was referred to our hospital due to progressive edema in the lower limbs and nephrotic range proteinuria. Five years previously, he underwent percutaneous angioplasty for left subclavian artery stenosis. Kidney biopsy revealed stage II MG. General examination including enhanced CT scan confirmed the presence of TA. He started oral prednisolone therapy at a dose of 40 mg daily. The C-reactive protein level normalized 7 days after the prednisolone therapy. Three months later, proteinuria had remitted. Though the true relationship between MG and TA was not revealed in present case, considering the fact that complete remission of nephrotic syndrome occurred following the improvement of C-reactive protein level in response to steroid therapy, TA might be the secondary cause of MG. To our best knowledge, only two case reports described the association of MG and TA previously. Those two patients, however, also demonstrated the feature of systemic lupus erythematosus in addition to TA. This is the first case report that describes a patient who presented as MG associated with TA, but not complicated by systemic lupus erythematosus.

Indexed as

Aortitis syndromeMembranous glomerulonephropathyNephrotic syndromeSystemic lupus erythematosusTakayasu's arteritis

Identifiers

PMID24847348
PMCPMC4025153
OpenAlexW2081189113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.